Global Canagliflozin API Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Canagliflozin is a C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It is a C-glycosyl compound, a member of thiophenes and an organofluorine compound.
LPI (LP Information)' newest research report, the “Canagliflozin API Industry Forecast” looks at past sales and reviews total world Canagliflozin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Canagliflozin API sales for 2023 through 2029. With Canagliflozin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canagliflozin API industry.
This Insight Report provides a comprehensive analysis of the global Canagliflozin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canagliflozin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Canagliflozin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canagliflozin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canagliflozin API.
The global Canagliflozin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Canagliflozin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Canagliflozin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Canagliflozin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Canagliflozin API players cover Dr. Reddy's Laboratories, Metrochem API Private Limited, Sun Pharmaceutical, Zhejiang Huahai Pharmaceutical, Indoco Remedies Ltd., Lupin Ltd, CAD Middle East Pharmaceutical Industries LLC, Melody Healthcare Pvt Ltd and Changzhou Pharmaceutical Factory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Canagliflozin API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Canagliflozin API market?
What factors are driving Canagliflozin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Canagliflozin API market opportunities vary by end market size?
How does Canagliflozin API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Canagliflozin is a C-glycosyl compound that is used (in its hemihydrate form) for treatment of type II diabetes via inhibition of sodium-glucose transport protein subtype 2. It has a role as a hypoglycemic agent and a sodium-glucose transport protein subtype 2 inhibitor. It is a C-glycosyl compound, a member of thiophenes and an organofluorine compound.
LPI (LP Information)' newest research report, the “Canagliflozin API Industry Forecast” looks at past sales and reviews total world Canagliflozin API sales in 2022, providing a comprehensive analysis by region and market sector of projected Canagliflozin API sales for 2023 through 2029. With Canagliflozin API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Canagliflozin API industry.
This Insight Report provides a comprehensive analysis of the global Canagliflozin API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Canagliflozin API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Canagliflozin API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Canagliflozin API and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Canagliflozin API.
The global Canagliflozin API market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Canagliflozin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Canagliflozin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Canagliflozin API is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Canagliflozin API players cover Dr. Reddy's Laboratories, Metrochem API Private Limited, Sun Pharmaceutical, Zhejiang Huahai Pharmaceutical, Indoco Remedies Ltd., Lupin Ltd, CAD Middle East Pharmaceutical Industries LLC, Melody Healthcare Pvt Ltd and Changzhou Pharmaceutical Factory, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Canagliflozin API market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Purity?98%
- Purity<98%
- Canagliflozin Tablets
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Dr. Reddy's Laboratories
- Metrochem API Private Limited
- Sun Pharmaceutical
- Zhejiang Huahai Pharmaceutical
- Indoco Remedies Ltd.
- Lupin Ltd
- CAD Middle East Pharmaceutical Industries LLC
- Melody Healthcare Pvt Ltd
- Changzhou Pharmaceutical Factory
- Glenmark Pharmaceuticals
What is the 10-year outlook for the global Canagliflozin API market?
What factors are driving Canagliflozin API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Canagliflozin API market opportunities vary by end market size?
How does Canagliflozin API break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Canagliflozin API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Canagliflozin API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Canagliflozin API by Country/Region, 2018, 2022 & 2029
2.2 Canagliflozin API Segment by Type
2.2.1 Purity?98%
2.2.2 Purity<98%
2.3 Canagliflozin API Sales by Type
2.3.1 Global Canagliflozin API Sales Market Share by Type (2018-2023)
2.3.2 Global Canagliflozin API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Canagliflozin API Sale Price by Type (2018-2023)
2.4 Canagliflozin API Segment by Application
2.4.1 Canagliflozin Tablets
2.4.2 Others
2.5 Canagliflozin API Sales by Application
2.5.1 Global Canagliflozin API Sale Market Share by Application (2018-2023)
2.5.2 Global Canagliflozin API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Canagliflozin API Sale Price by Application (2018-2023)
3 GLOBAL CANAGLIFLOZIN API BY COMPANY
3.1 Global Canagliflozin API Breakdown Data by Company
3.1.1 Global Canagliflozin API Annual Sales by Company (2018-2023)
3.1.2 Global Canagliflozin API Sales Market Share by Company (2018-2023)
3.2 Global Canagliflozin API Annual Revenue by Company (2018-2023)
3.2.1 Global Canagliflozin API Revenue by Company (2018-2023)
3.2.2 Global Canagliflozin API Revenue Market Share by Company (2018-2023)
3.3 Global Canagliflozin API Sale Price by Company
3.4 Key Manufacturers Canagliflozin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Canagliflozin API Product Location Distribution
3.4.2 Players Canagliflozin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CANAGLIFLOZIN API BY GEOGRAPHIC REGION
4.1 World Historic Canagliflozin API Market Size by Geographic Region (2018-2023)
4.1.1 Global Canagliflozin API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Canagliflozin API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Canagliflozin API Market Size by Country/Region (2018-2023)
4.2.1 Global Canagliflozin API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Canagliflozin API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Canagliflozin API Sales Growth
4.4 APAC Canagliflozin API Sales Growth
4.5 Europe Canagliflozin API Sales Growth
4.6 Middle East & Africa Canagliflozin API Sales Growth
5 AMERICAS
5.1 Americas Canagliflozin API Sales by Country
5.1.1 Americas Canagliflozin API Sales by Country (2018-2023)
5.1.2 Americas Canagliflozin API Revenue by Country (2018-2023)
5.2 Americas Canagliflozin API Sales by Type
5.3 Americas Canagliflozin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canagliflozin API Sales by Region
6.1.1 APAC Canagliflozin API Sales by Region (2018-2023)
6.1.2 APAC Canagliflozin API Revenue by Region (2018-2023)
6.2 APAC Canagliflozin API Sales by Type
6.3 APAC Canagliflozin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Canagliflozin API by Country
7.1.1 Europe Canagliflozin API Sales by Country (2018-2023)
7.1.2 Europe Canagliflozin API Revenue by Country (2018-2023)
7.2 Europe Canagliflozin API Sales by Type
7.3 Europe Canagliflozin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Canagliflozin API by Country
8.1.1 Middle East & Africa Canagliflozin API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Canagliflozin API Revenue by Country (2018-2023)
8.2 Middle East & Africa Canagliflozin API Sales by Type
8.3 Middle East & Africa Canagliflozin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Canagliflozin API
10.3 Manufacturing Process Analysis of Canagliflozin API
10.4 Industry Chain Structure of Canagliflozin API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Canagliflozin API Distributors
11.3 Canagliflozin API Customer
12 WORLD FORECAST REVIEW FOR CANAGLIFLOZIN API BY GEOGRAPHIC REGION
12.1 Global Canagliflozin API Market Size Forecast by Region
12.1.1 Global Canagliflozin API Forecast by Region (2024-2029)
12.1.2 Global Canagliflozin API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Canagliflozin API Forecast by Type
12.7 Global Canagliflozin API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy's Laboratories
13.1.1 Dr. Reddy's Laboratories Company Information
13.1.2 Dr. Reddy's Laboratories Canagliflozin API Product Portfolios and Specifications
13.1.3 Dr. Reddy's Laboratories Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dr. Reddy's Laboratories Main Business Overview
13.1.5 Dr. Reddy's Laboratories Latest Developments
13.2 Metrochem API Private Limited
13.2.1 Metrochem API Private Limited Company Information
13.2.2 Metrochem API Private Limited Canagliflozin API Product Portfolios and Specifications
13.2.3 Metrochem API Private Limited Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Metrochem API Private Limited Main Business Overview
13.2.5 Metrochem API Private Limited Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Canagliflozin API Product Portfolios and Specifications
13.3.3 Sun Pharmaceutical Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Zhejiang Huahai Pharmaceutical
13.4.1 Zhejiang Huahai Pharmaceutical Company Information
13.4.2 Zhejiang Huahai Pharmaceutical Canagliflozin API Product Portfolios and Specifications
13.4.3 Zhejiang Huahai Pharmaceutical Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.4.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.5 Indoco Remedies Ltd.
13.5.1 Indoco Remedies Ltd. Company Information
13.5.2 Indoco Remedies Ltd. Canagliflozin API Product Portfolios and Specifications
13.5.3 Indoco Remedies Ltd. Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Indoco Remedies Ltd. Main Business Overview
13.5.5 Indoco Remedies Ltd. Latest Developments
13.6 Lupin Ltd
13.6.1 Lupin Ltd Company Information
13.6.2 Lupin Ltd Canagliflozin API Product Portfolios and Specifications
13.6.3 Lupin Ltd Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lupin Ltd Main Business Overview
13.6.5 Lupin Ltd Latest Developments
13.7 CAD Middle East Pharmaceutical Industries LLC
13.7.1 CAD Middle East Pharmaceutical Industries LLC Company Information
13.7.2 CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Product Portfolios and Specifications
13.7.3 CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CAD Middle East Pharmaceutical Industries LLC Main Business Overview
13.7.5 CAD Middle East Pharmaceutical Industries LLC Latest Developments
13.8 Melody Healthcare Pvt Ltd
13.8.1 Melody Healthcare Pvt Ltd Company Information
13.8.2 Melody Healthcare Pvt Ltd Canagliflozin API Product Portfolios and Specifications
13.8.3 Melody Healthcare Pvt Ltd Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Melody Healthcare Pvt Ltd Main Business Overview
13.8.5 Melody Healthcare Pvt Ltd Latest Developments
13.9 Changzhou Pharmaceutical Factory
13.9.1 Changzhou Pharmaceutical Factory Company Information
13.9.2 Changzhou Pharmaceutical Factory Canagliflozin API Product Portfolios and Specifications
13.9.3 Changzhou Pharmaceutical Factory Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changzhou Pharmaceutical Factory Main Business Overview
13.9.5 Changzhou Pharmaceutical Factory Latest Developments
13.10 Glenmark Pharmaceuticals
13.10.1 Glenmark Pharmaceuticals Company Information
13.10.2 Glenmark Pharmaceuticals Canagliflozin API Product Portfolios and Specifications
13.10.3 Glenmark Pharmaceuticals Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Glenmark Pharmaceuticals Main Business Overview
13.10.5 Glenmark Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Canagliflozin API Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Canagliflozin API by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Canagliflozin API by Country/Region, 2018, 2022 & 2029
2.2 Canagliflozin API Segment by Type
2.2.1 Purity?98%
2.2.2 Purity<98%
2.3 Canagliflozin API Sales by Type
2.3.1 Global Canagliflozin API Sales Market Share by Type (2018-2023)
2.3.2 Global Canagliflozin API Revenue and Market Share by Type (2018-2023)
2.3.3 Global Canagliflozin API Sale Price by Type (2018-2023)
2.4 Canagliflozin API Segment by Application
2.4.1 Canagliflozin Tablets
2.4.2 Others
2.5 Canagliflozin API Sales by Application
2.5.1 Global Canagliflozin API Sale Market Share by Application (2018-2023)
2.5.2 Global Canagliflozin API Revenue and Market Share by Application (2018-2023)
2.5.3 Global Canagliflozin API Sale Price by Application (2018-2023)
3 GLOBAL CANAGLIFLOZIN API BY COMPANY
3.1 Global Canagliflozin API Breakdown Data by Company
3.1.1 Global Canagliflozin API Annual Sales by Company (2018-2023)
3.1.2 Global Canagliflozin API Sales Market Share by Company (2018-2023)
3.2 Global Canagliflozin API Annual Revenue by Company (2018-2023)
3.2.1 Global Canagliflozin API Revenue by Company (2018-2023)
3.2.2 Global Canagliflozin API Revenue Market Share by Company (2018-2023)
3.3 Global Canagliflozin API Sale Price by Company
3.4 Key Manufacturers Canagliflozin API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Canagliflozin API Product Location Distribution
3.4.2 Players Canagliflozin API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CANAGLIFLOZIN API BY GEOGRAPHIC REGION
4.1 World Historic Canagliflozin API Market Size by Geographic Region (2018-2023)
4.1.1 Global Canagliflozin API Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Canagliflozin API Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Canagliflozin API Market Size by Country/Region (2018-2023)
4.2.1 Global Canagliflozin API Annual Sales by Country/Region (2018-2023)
4.2.2 Global Canagliflozin API Annual Revenue by Country/Region (2018-2023)
4.3 Americas Canagliflozin API Sales Growth
4.4 APAC Canagliflozin API Sales Growth
4.5 Europe Canagliflozin API Sales Growth
4.6 Middle East & Africa Canagliflozin API Sales Growth
5 AMERICAS
5.1 Americas Canagliflozin API Sales by Country
5.1.1 Americas Canagliflozin API Sales by Country (2018-2023)
5.1.2 Americas Canagliflozin API Revenue by Country (2018-2023)
5.2 Americas Canagliflozin API Sales by Type
5.3 Americas Canagliflozin API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Canagliflozin API Sales by Region
6.1.1 APAC Canagliflozin API Sales by Region (2018-2023)
6.1.2 APAC Canagliflozin API Revenue by Region (2018-2023)
6.2 APAC Canagliflozin API Sales by Type
6.3 APAC Canagliflozin API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Canagliflozin API by Country
7.1.1 Europe Canagliflozin API Sales by Country (2018-2023)
7.1.2 Europe Canagliflozin API Revenue by Country (2018-2023)
7.2 Europe Canagliflozin API Sales by Type
7.3 Europe Canagliflozin API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Canagliflozin API by Country
8.1.1 Middle East & Africa Canagliflozin API Sales by Country (2018-2023)
8.1.2 Middle East & Africa Canagliflozin API Revenue by Country (2018-2023)
8.2 Middle East & Africa Canagliflozin API Sales by Type
8.3 Middle East & Africa Canagliflozin API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Canagliflozin API
10.3 Manufacturing Process Analysis of Canagliflozin API
10.4 Industry Chain Structure of Canagliflozin API
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Canagliflozin API Distributors
11.3 Canagliflozin API Customer
12 WORLD FORECAST REVIEW FOR CANAGLIFLOZIN API BY GEOGRAPHIC REGION
12.1 Global Canagliflozin API Market Size Forecast by Region
12.1.1 Global Canagliflozin API Forecast by Region (2024-2029)
12.1.2 Global Canagliflozin API Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Canagliflozin API Forecast by Type
12.7 Global Canagliflozin API Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Dr. Reddy's Laboratories
13.1.1 Dr. Reddy's Laboratories Company Information
13.1.2 Dr. Reddy's Laboratories Canagliflozin API Product Portfolios and Specifications
13.1.3 Dr. Reddy's Laboratories Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Dr. Reddy's Laboratories Main Business Overview
13.1.5 Dr. Reddy's Laboratories Latest Developments
13.2 Metrochem API Private Limited
13.2.1 Metrochem API Private Limited Company Information
13.2.2 Metrochem API Private Limited Canagliflozin API Product Portfolios and Specifications
13.2.3 Metrochem API Private Limited Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Metrochem API Private Limited Main Business Overview
13.2.5 Metrochem API Private Limited Latest Developments
13.3 Sun Pharmaceutical
13.3.1 Sun Pharmaceutical Company Information
13.3.2 Sun Pharmaceutical Canagliflozin API Product Portfolios and Specifications
13.3.3 Sun Pharmaceutical Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Sun Pharmaceutical Main Business Overview
13.3.5 Sun Pharmaceutical Latest Developments
13.4 Zhejiang Huahai Pharmaceutical
13.4.1 Zhejiang Huahai Pharmaceutical Company Information
13.4.2 Zhejiang Huahai Pharmaceutical Canagliflozin API Product Portfolios and Specifications
13.4.3 Zhejiang Huahai Pharmaceutical Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Zhejiang Huahai Pharmaceutical Main Business Overview
13.4.5 Zhejiang Huahai Pharmaceutical Latest Developments
13.5 Indoco Remedies Ltd.
13.5.1 Indoco Remedies Ltd. Company Information
13.5.2 Indoco Remedies Ltd. Canagliflozin API Product Portfolios and Specifications
13.5.3 Indoco Remedies Ltd. Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Indoco Remedies Ltd. Main Business Overview
13.5.5 Indoco Remedies Ltd. Latest Developments
13.6 Lupin Ltd
13.6.1 Lupin Ltd Company Information
13.6.2 Lupin Ltd Canagliflozin API Product Portfolios and Specifications
13.6.3 Lupin Ltd Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Lupin Ltd Main Business Overview
13.6.5 Lupin Ltd Latest Developments
13.7 CAD Middle East Pharmaceutical Industries LLC
13.7.1 CAD Middle East Pharmaceutical Industries LLC Company Information
13.7.2 CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Product Portfolios and Specifications
13.7.3 CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 CAD Middle East Pharmaceutical Industries LLC Main Business Overview
13.7.5 CAD Middle East Pharmaceutical Industries LLC Latest Developments
13.8 Melody Healthcare Pvt Ltd
13.8.1 Melody Healthcare Pvt Ltd Company Information
13.8.2 Melody Healthcare Pvt Ltd Canagliflozin API Product Portfolios and Specifications
13.8.3 Melody Healthcare Pvt Ltd Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Melody Healthcare Pvt Ltd Main Business Overview
13.8.5 Melody Healthcare Pvt Ltd Latest Developments
13.9 Changzhou Pharmaceutical Factory
13.9.1 Changzhou Pharmaceutical Factory Company Information
13.9.2 Changzhou Pharmaceutical Factory Canagliflozin API Product Portfolios and Specifications
13.9.3 Changzhou Pharmaceutical Factory Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Changzhou Pharmaceutical Factory Main Business Overview
13.9.5 Changzhou Pharmaceutical Factory Latest Developments
13.10 Glenmark Pharmaceuticals
13.10.1 Glenmark Pharmaceuticals Company Information
13.10.2 Glenmark Pharmaceuticals Canagliflozin API Product Portfolios and Specifications
13.10.3 Glenmark Pharmaceuticals Canagliflozin API Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Glenmark Pharmaceuticals Main Business Overview
13.10.5 Glenmark Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Canagliflozin API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Canagliflozin API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity<98%
Table 5. Global Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 6. Global Canagliflozin API Sales Market Share by Type (2018-2023)
Table 7. Global Canagliflozin API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Canagliflozin API Revenue Market Share by Type (2018-2023)
Table 9. Global Canagliflozin API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 11. Global Canagliflozin API Sales Market Share by Application (2018-2023)
Table 12. Global Canagliflozin API Revenue by Application (2018-2023)
Table 13. Global Canagliflozin API Revenue Market Share by Application (2018-2023)
Table 14. Global Canagliflozin API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Canagliflozin API Sales by Company (2018-2023) & (Ton)
Table 16. Global Canagliflozin API Sales Market Share by Company (2018-2023)
Table 17. Global Canagliflozin API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Canagliflozin API Revenue Market Share by Company (2018-2023)
Table 19. Global Canagliflozin API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Canagliflozin API Producing Area Distribution and Sales Area
Table 21. Players Canagliflozin API Products Offered
Table 22. Canagliflozin API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Canagliflozin API Sales by Geographic Region (2018-2023) & (Ton)
Table 26. Global Canagliflozin API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Canagliflozin API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Canagliflozin API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Canagliflozin API Sales by Country/Region (2018-2023) & (Ton)
Table 30. Global Canagliflozin API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Canagliflozin API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Canagliflozin API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Canagliflozin API Sales by Country (2018-2023) & (Ton)
Table 34. Americas Canagliflozin API Sales Market Share by Country (2018-2023)
Table 35. Americas Canagliflozin API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Canagliflozin API Revenue Market Share by Country (2018-2023)
Table 37. Americas Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 38. Americas Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 39. APAC Canagliflozin API Sales by Region (2018-2023) & (Ton)
Table 40. APAC Canagliflozin API Sales Market Share by Region (2018-2023)
Table 41. APAC Canagliflozin API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Canagliflozin API Revenue Market Share by Region (2018-2023)
Table 43. APAC Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 44. APAC Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 45. Europe Canagliflozin API Sales by Country (2018-2023) & (Ton)
Table 46. Europe Canagliflozin API Sales Market Share by Country (2018-2023)
Table 47. Europe Canagliflozin API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Canagliflozin API Revenue Market Share by Country (2018-2023)
Table 49. Europe Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 50. Europe Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 51. Middle East & Africa Canagliflozin API Sales by Country (2018-2023) & (Ton)
Table 52. Middle East & Africa Canagliflozin API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Canagliflozin API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Canagliflozin API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 56. Middle East & Africa Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 57. Key Market Drivers & Growth Opportunities of Canagliflozin API
Table 58. Key Market Challenges & Risks of Canagliflozin API
Table 59. Key Industry Trends of Canagliflozin API
Table 60. Canagliflozin API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Canagliflozin API Distributors List
Table 63. Canagliflozin API Customer List
Table 64. Global Canagliflozin API Sales Forecast by Region (2024-2029) & (Ton)
Table 65. Global Canagliflozin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Canagliflozin API Sales Forecast by Country (2024-2029) & (Ton)
Table 67. Americas Canagliflozin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Canagliflozin API Sales Forecast by Region (2024-2029) & (Ton)
Table 69. APAC Canagliflozin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Canagliflozin API Sales Forecast by Country (2024-2029) & (Ton)
Table 71. Europe Canagliflozin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Canagliflozin API Sales Forecast by Country (2024-2029) & (Ton)
Table 73. Middle East & Africa Canagliflozin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Canagliflozin API Sales Forecast by Type (2024-2029) & (Ton)
Table 75. Global Canagliflozin API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Canagliflozin API Sales Forecast by Application (2024-2029) & (Ton)
Table 77. Global Canagliflozin API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Dr. Reddy's Laboratories Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 79. Dr. Reddy's Laboratories Canagliflozin API Product Portfolios and Specifications
Table 80. Dr. Reddy's Laboratories Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Dr. Reddy's Laboratories Main Business
Table 82. Dr. Reddy's Laboratories Latest Developments
Table 83. Metrochem API Private Limited Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 84. Metrochem API Private Limited Canagliflozin API Product Portfolios and Specifications
Table 85. Metrochem API Private Limited Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Metrochem API Private Limited Main Business
Table 87. Metrochem API Private Limited Latest Developments
Table 88. Sun Pharmaceutical Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Sun Pharmaceutical Canagliflozin API Product Portfolios and Specifications
Table 90. Sun Pharmaceutical Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Sun Pharmaceutical Main Business
Table 92. Sun Pharmaceutical Latest Developments
Table 93. Zhejiang Huahai Pharmaceutical Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhejiang Huahai Pharmaceutical Canagliflozin API Product Portfolios and Specifications
Table 95. Zhejiang Huahai Pharmaceutical Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Zhejiang Huahai Pharmaceutical Main Business
Table 97. Zhejiang Huahai Pharmaceutical Latest Developments
Table 98. Indoco Remedies Ltd. Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 99. Indoco Remedies Ltd. Canagliflozin API Product Portfolios and Specifications
Table 100. Indoco Remedies Ltd. Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Indoco Remedies Ltd. Main Business
Table 102. Indoco Remedies Ltd. Latest Developments
Table 103. Lupin Ltd Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Lupin Ltd Canagliflozin API Product Portfolios and Specifications
Table 105. Lupin Ltd Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Lupin Ltd Main Business
Table 107. Lupin Ltd Latest Developments
Table 108. CAD Middle East Pharmaceutical Industries LLC Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 109. CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Product Portfolios and Specifications
Table 110. CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. CAD Middle East Pharmaceutical Industries LLC Main Business
Table 112. CAD Middle East Pharmaceutical Industries LLC Latest Developments
Table 113. Melody Healthcare Pvt Ltd Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Melody Healthcare Pvt Ltd Canagliflozin API Product Portfolios and Specifications
Table 115. Melody Healthcare Pvt Ltd Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Melody Healthcare Pvt Ltd Main Business
Table 117. Melody Healthcare Pvt Ltd Latest Developments
Table 118. Changzhou Pharmaceutical Factory Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 119. Changzhou Pharmaceutical Factory Canagliflozin API Product Portfolios and Specifications
Table 120. Changzhou Pharmaceutical Factory Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Changzhou Pharmaceutical Factory Main Business
Table 122. Changzhou Pharmaceutical Factory Latest Developments
Table 123. Glenmark Pharmaceuticals Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 124. Glenmark Pharmaceuticals Canagliflozin API Product Portfolios and Specifications
Table 125. Glenmark Pharmaceuticals Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Glenmark Pharmaceuticals Main Business
Table 127. Glenmark Pharmaceuticals Latest Developments
Table 1. Canagliflozin API Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Canagliflozin API Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Purity?98%
Table 4. Major Players of Purity<98%
Table 5. Global Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 6. Global Canagliflozin API Sales Market Share by Type (2018-2023)
Table 7. Global Canagliflozin API Revenue by Type (2018-2023) & ($ million)
Table 8. Global Canagliflozin API Revenue Market Share by Type (2018-2023)
Table 9. Global Canagliflozin API Sale Price by Type (2018-2023) & (US$/Ton)
Table 10. Global Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 11. Global Canagliflozin API Sales Market Share by Application (2018-2023)
Table 12. Global Canagliflozin API Revenue by Application (2018-2023)
Table 13. Global Canagliflozin API Revenue Market Share by Application (2018-2023)
Table 14. Global Canagliflozin API Sale Price by Application (2018-2023) & (US$/Ton)
Table 15. Global Canagliflozin API Sales by Company (2018-2023) & (Ton)
Table 16. Global Canagliflozin API Sales Market Share by Company (2018-2023)
Table 17. Global Canagliflozin API Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Canagliflozin API Revenue Market Share by Company (2018-2023)
Table 19. Global Canagliflozin API Sale Price by Company (2018-2023) & (US$/Ton)
Table 20. Key Manufacturers Canagliflozin API Producing Area Distribution and Sales Area
Table 21. Players Canagliflozin API Products Offered
Table 22. Canagliflozin API Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Canagliflozin API Sales by Geographic Region (2018-2023) & (Ton)
Table 26. Global Canagliflozin API Sales Market Share Geographic Region (2018-2023)
Table 27. Global Canagliflozin API Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Canagliflozin API Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Canagliflozin API Sales by Country/Region (2018-2023) & (Ton)
Table 30. Global Canagliflozin API Sales Market Share by Country/Region (2018-2023)
Table 31. Global Canagliflozin API Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Canagliflozin API Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Canagliflozin API Sales by Country (2018-2023) & (Ton)
Table 34. Americas Canagliflozin API Sales Market Share by Country (2018-2023)
Table 35. Americas Canagliflozin API Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Canagliflozin API Revenue Market Share by Country (2018-2023)
Table 37. Americas Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 38. Americas Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 39. APAC Canagliflozin API Sales by Region (2018-2023) & (Ton)
Table 40. APAC Canagliflozin API Sales Market Share by Region (2018-2023)
Table 41. APAC Canagliflozin API Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Canagliflozin API Revenue Market Share by Region (2018-2023)
Table 43. APAC Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 44. APAC Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 45. Europe Canagliflozin API Sales by Country (2018-2023) & (Ton)
Table 46. Europe Canagliflozin API Sales Market Share by Country (2018-2023)
Table 47. Europe Canagliflozin API Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Canagliflozin API Revenue Market Share by Country (2018-2023)
Table 49. Europe Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 50. Europe Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 51. Middle East & Africa Canagliflozin API Sales by Country (2018-2023) & (Ton)
Table 52. Middle East & Africa Canagliflozin API Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Canagliflozin API Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Canagliflozin API Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Canagliflozin API Sales by Type (2018-2023) & (Ton)
Table 56. Middle East & Africa Canagliflozin API Sales by Application (2018-2023) & (Ton)
Table 57. Key Market Drivers & Growth Opportunities of Canagliflozin API
Table 58. Key Market Challenges & Risks of Canagliflozin API
Table 59. Key Industry Trends of Canagliflozin API
Table 60. Canagliflozin API Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Canagliflozin API Distributors List
Table 63. Canagliflozin API Customer List
Table 64. Global Canagliflozin API Sales Forecast by Region (2024-2029) & (Ton)
Table 65. Global Canagliflozin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Canagliflozin API Sales Forecast by Country (2024-2029) & (Ton)
Table 67. Americas Canagliflozin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Canagliflozin API Sales Forecast by Region (2024-2029) & (Ton)
Table 69. APAC Canagliflozin API Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Canagliflozin API Sales Forecast by Country (2024-2029) & (Ton)
Table 71. Europe Canagliflozin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Canagliflozin API Sales Forecast by Country (2024-2029) & (Ton)
Table 73. Middle East & Africa Canagliflozin API Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Canagliflozin API Sales Forecast by Type (2024-2029) & (Ton)
Table 75. Global Canagliflozin API Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Canagliflozin API Sales Forecast by Application (2024-2029) & (Ton)
Table 77. Global Canagliflozin API Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Dr. Reddy's Laboratories Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 79. Dr. Reddy's Laboratories Canagliflozin API Product Portfolios and Specifications
Table 80. Dr. Reddy's Laboratories Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 81. Dr. Reddy's Laboratories Main Business
Table 82. Dr. Reddy's Laboratories Latest Developments
Table 83. Metrochem API Private Limited Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 84. Metrochem API Private Limited Canagliflozin API Product Portfolios and Specifications
Table 85. Metrochem API Private Limited Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 86. Metrochem API Private Limited Main Business
Table 87. Metrochem API Private Limited Latest Developments
Table 88. Sun Pharmaceutical Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 89. Sun Pharmaceutical Canagliflozin API Product Portfolios and Specifications
Table 90. Sun Pharmaceutical Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 91. Sun Pharmaceutical Main Business
Table 92. Sun Pharmaceutical Latest Developments
Table 93. Zhejiang Huahai Pharmaceutical Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 94. Zhejiang Huahai Pharmaceutical Canagliflozin API Product Portfolios and Specifications
Table 95. Zhejiang Huahai Pharmaceutical Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 96. Zhejiang Huahai Pharmaceutical Main Business
Table 97. Zhejiang Huahai Pharmaceutical Latest Developments
Table 98. Indoco Remedies Ltd. Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 99. Indoco Remedies Ltd. Canagliflozin API Product Portfolios and Specifications
Table 100. Indoco Remedies Ltd. Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 101. Indoco Remedies Ltd. Main Business
Table 102. Indoco Remedies Ltd. Latest Developments
Table 103. Lupin Ltd Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 104. Lupin Ltd Canagliflozin API Product Portfolios and Specifications
Table 105. Lupin Ltd Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 106. Lupin Ltd Main Business
Table 107. Lupin Ltd Latest Developments
Table 108. CAD Middle East Pharmaceutical Industries LLC Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 109. CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Product Portfolios and Specifications
Table 110. CAD Middle East Pharmaceutical Industries LLC Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 111. CAD Middle East Pharmaceutical Industries LLC Main Business
Table 112. CAD Middle East Pharmaceutical Industries LLC Latest Developments
Table 113. Melody Healthcare Pvt Ltd Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 114. Melody Healthcare Pvt Ltd Canagliflozin API Product Portfolios and Specifications
Table 115. Melody Healthcare Pvt Ltd Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 116. Melody Healthcare Pvt Ltd Main Business
Table 117. Melody Healthcare Pvt Ltd Latest Developments
Table 118. Changzhou Pharmaceutical Factory Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 119. Changzhou Pharmaceutical Factory Canagliflozin API Product Portfolios and Specifications
Table 120. Changzhou Pharmaceutical Factory Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 121. Changzhou Pharmaceutical Factory Main Business
Table 122. Changzhou Pharmaceutical Factory Latest Developments
Table 123. Glenmark Pharmaceuticals Basic Information, Canagliflozin API Manufacturing Base, Sales Area and Its Competitors
Table 124. Glenmark Pharmaceuticals Canagliflozin API Product Portfolios and Specifications
Table 125. Glenmark Pharmaceuticals Canagliflozin API Sales (Ton), Revenue ($ Million), Price (US$/Ton) and Gross Margin (2018-2023)
Table 126. Glenmark Pharmaceuticals Main Business
Table 127. Glenmark Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of Canagliflozin API
Figure 2. Canagliflozin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canagliflozin API Sales Growth Rate 2018-2029 (Ton)
Figure 7. Global Canagliflozin API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Canagliflozin API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity?98%
Figure 10. Product Picture of Purity<98%
Figure 11. Global Canagliflozin API Sales Market Share by Type in 2022
Figure 12. Global Canagliflozin API Revenue Market Share by Type (2018-2023)
Figure 13. Canagliflozin API Consumed in Canagliflozin Tablets
Figure 14. Global Canagliflozin API Market: Canagliflozin Tablets (2018-2023) & (Ton)
Figure 15. Canagliflozin API Consumed in Others
Figure 16. Global Canagliflozin API Market: Others (2018-2023) & (Ton)
Figure 17. Global Canagliflozin API Sales Market Share by Application (2022)
Figure 18. Global Canagliflozin API Revenue Market Share by Application in 2022
Figure 19. Canagliflozin API Sales Market by Company in 2022 (Ton)
Figure 20. Global Canagliflozin API Sales Market Share by Company in 2022
Figure 21. Canagliflozin API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Canagliflozin API Revenue Market Share by Company in 2022
Figure 23. Global Canagliflozin API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Canagliflozin API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Canagliflozin API Sales 2018-2023 (Ton)
Figure 26. Americas Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Canagliflozin API Sales 2018-2023 (Ton)
Figure 28. APAC Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Canagliflozin API Sales 2018-2023 (Ton)
Figure 30. Europe Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Canagliflozin API Sales 2018-2023 (Ton)
Figure 32. Middle East & Africa Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Canagliflozin API Sales Market Share by Country in 2022
Figure 34. Americas Canagliflozin API Revenue Market Share by Country in 2022
Figure 35. Americas Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 36. Americas Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 37. United States Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Canagliflozin API Sales Market Share by Region in 2022
Figure 42. APAC Canagliflozin API Revenue Market Share by Regions in 2022
Figure 43. APAC Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 44. APAC Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 45. China Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Canagliflozin API Sales Market Share by Country in 2022
Figure 53. Europe Canagliflozin API Revenue Market Share by Country in 2022
Figure 54. Europe Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 55. Europe Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 56. Germany Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Canagliflozin API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Canagliflozin API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Canagliflozin API in 2022
Figure 71. Manufacturing Process Analysis of Canagliflozin API
Figure 72. Industry Chain Structure of Canagliflozin API
Figure 73. Channels of Distribution
Figure 74. Global Canagliflozin API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Canagliflozin API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Canagliflozin API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Canagliflozin API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Canagliflozin API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Canagliflozin API Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Canagliflozin API
Figure 2. Canagliflozin API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Canagliflozin API Sales Growth Rate 2018-2029 (Ton)
Figure 7. Global Canagliflozin API Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Canagliflozin API Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Purity?98%
Figure 10. Product Picture of Purity<98%
Figure 11. Global Canagliflozin API Sales Market Share by Type in 2022
Figure 12. Global Canagliflozin API Revenue Market Share by Type (2018-2023)
Figure 13. Canagliflozin API Consumed in Canagliflozin Tablets
Figure 14. Global Canagliflozin API Market: Canagliflozin Tablets (2018-2023) & (Ton)
Figure 15. Canagliflozin API Consumed in Others
Figure 16. Global Canagliflozin API Market: Others (2018-2023) & (Ton)
Figure 17. Global Canagliflozin API Sales Market Share by Application (2022)
Figure 18. Global Canagliflozin API Revenue Market Share by Application in 2022
Figure 19. Canagliflozin API Sales Market by Company in 2022 (Ton)
Figure 20. Global Canagliflozin API Sales Market Share by Company in 2022
Figure 21. Canagliflozin API Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Canagliflozin API Revenue Market Share by Company in 2022
Figure 23. Global Canagliflozin API Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Canagliflozin API Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Canagliflozin API Sales 2018-2023 (Ton)
Figure 26. Americas Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 27. APAC Canagliflozin API Sales 2018-2023 (Ton)
Figure 28. APAC Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 29. Europe Canagliflozin API Sales 2018-2023 (Ton)
Figure 30. Europe Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Canagliflozin API Sales 2018-2023 (Ton)
Figure 32. Middle East & Africa Canagliflozin API Revenue 2018-2023 ($ Millions)
Figure 33. Americas Canagliflozin API Sales Market Share by Country in 2022
Figure 34. Americas Canagliflozin API Revenue Market Share by Country in 2022
Figure 35. Americas Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 36. Americas Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 37. United States Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Canagliflozin API Sales Market Share by Region in 2022
Figure 42. APAC Canagliflozin API Revenue Market Share by Regions in 2022
Figure 43. APAC Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 44. APAC Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 45. China Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Canagliflozin API Sales Market Share by Country in 2022
Figure 53. Europe Canagliflozin API Revenue Market Share by Country in 2022
Figure 54. Europe Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 55. Europe Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 56. Germany Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Canagliflozin API Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Canagliflozin API Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Canagliflozin API Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Canagliflozin API Sales Market Share by Application (2018-2023)
Figure 65. Egypt Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Canagliflozin API Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Canagliflozin API in 2022
Figure 71. Manufacturing Process Analysis of Canagliflozin API
Figure 72. Industry Chain Structure of Canagliflozin API
Figure 73. Channels of Distribution
Figure 74. Global Canagliflozin API Sales Market Forecast by Region (2024-2029)
Figure 75. Global Canagliflozin API Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Canagliflozin API Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Canagliflozin API Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Canagliflozin API Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Canagliflozin API Revenue Market Share Forecast by Application (2024-2029)
